Plus Therapeutics Partners with GTC to Expand CNSide Platform
HOUSTON & LAKE FOREST, Calif., July 16, 2026 Plus Therapeutics and Genomic Testing Cooperative (GTC) announced a strategic collaboration...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
HOUSTON & LAKE FOREST, Calif., July 16, 2026 Plus Therapeutics and Genomic Testing Cooperative (GTC) announced a strategic collaboration...
LAUSANNE, Switzerland, July 13, 2026 Vandria announced new Phase 1 clinical data demonstrating that its investigational small molecule VNA-318...
